19KA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - CorMedix Inc

Watchlist Manager

Watchlist

Price: 7.028 EUR -0.76% Market Closed

Market Cap: €386.4m

C	CorMedix Inc F:19KA	US
	Rhythm Pharmaceuticals Inc NASDAQ:RYTM	US
C	Cadence Design Systems Inc DUS:CDS	US

Profitability Summary

CorMedix Inc's profitability score is 59/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

83%

Strong 3Y Average Gross Margin

75%

Declining Gross Margin

100% > 83%

Exceptional Operating Margin

47%

Negative 3Y Average Operating Margin

-14 636%

Operating Margin is Increasing

-95 425% > 47%

Exceptional Net Margin

40%

Negative 3Y Average Net Margin

-13 936%

Net Margin is Increasing

-92 250% > 40%

Exceptional Free Cash Flow Margin

54%

Negative 3Y Average Free Cash Flow Margin

-11 999%

Free Cash Flow Margin is Increasing

-78 375% > 54%

Exceptional ROE

55%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-664%

ROIC is Increasing

-3 235% > 58%

View All

Hide

Collapse

59 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.